Pediatr Blood Cancer. 2004 Nov;43(6):703-5.

Use of recombinant factor VIIa (rFVIIa) to control intraoperative bleeding in pediatric brain tumor patients.

Heisel M, Nagib M, Madsen L, Alshiekh M, Bendel A.

Source

Children's Hospitals and Clinics, Department of Hematology/Oncology, Minneapolis, Minnesota 55404, USA. Margaret.Heisel@childrenshc.org

Abstract

Surgical bleeding during the resection of brain tumors in children may be related to tumor vascularity, pathology, and location. Despite improvements in neurosurgical technique, neuroanesthesia, and blood product replacement, bleeding can be life-threatening in these surgeries. We report eight pediatric patients in whom recombinant factor VIIa (rFVIIa) was used to control intraoperative bleeding during surgical resection of pediatric brain tumors. rFVIIa should be considered as a method to control intraoperative bleeding that is unresponsive to conventional interventions. Additional studies are needed to determine optimal patient selection and drug dosing, efficacy and safety.

PMID:: 15390292; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery. [Eur J Cardiothorac Surg. 2005]
Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery.
Hyllner M, Houltz E, Jeppsson A. Eur J Cardiothorac Surg. 2005 Aug; 28(2):254-8.
[Recombinant factor VII (NovoSeven) in intraoperative blood saving during neurosurgical treatment of the brain arteriovenous malformation]. [Vojnosanit Pregl. 2007]
[Recombinant factor VII (NovoSeven) in intraoperative blood saving during neurosurgical treatment of the brain arteriovenous malformation].
Novak V, Petrović B, Calija B, Mitov L, Rancić Z. Vojnosanit Pregl. 2007 Feb; 64(2):151-4.
Recombinant activated factor VII in spinal surgery: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial. [Spine (Phila Pa 1976). 2007]
Recombinant activated factor VII in spinal surgery: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial.
Sachs B, Delacy D, Green J, Graham RS, Ramsay J, Kreisler N, Kruse P, Khutoryansky N, Hu SS. Spine (Phila Pa 1976). 2007 Oct 1; 32(21):2285-93.
Review Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review. [Blood Rev. 2003]
Review Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review.
Grounds M. Blood Rev. 2003 Sep; 17 Suppl 1:S11-21.
Review Potential role of recombinant factor VIIa as a hemostatic agent. [Clin Adv Hematol Oncol. 2003]
Review Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U, Erhardtsen E. Clin Adv Hematol Oncol. 2003 Feb; 1(2):112-9.

See reviews... See all...

Cited by 1 PubMed Central article

Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial. [Crit Care. 2007]
Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial.
Kluger Y, Riou B, Rossaint R, Rizoli SB, Boffard KD, Choong PI, Warren B, Tillinger M. Crit Care. 2007; 11(4):R85.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Use of recombinant factor VIIa (rFVIIa) to control intraoperative bleeding in pe...
Use of recombinant factor VIIa (rFVIIa) to control intraoperative bleeding in pediatric brain tumor patients.
Pediatr Blood Cancer. 2004 Nov ;43(6):703-5.

PubMed
The concepts of stress and stress system disorders. Overview of physical and beh...
The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis.
JAMA. 1992 Mar 4 ;267(9):1244-52.

PubMed
The effects of remifentanil on endotracheal suctioning-induced increases in intr...
The effects of remifentanil on endotracheal suctioning-induced increases in intracranial pressure in head-injured patients.
Anesth Analg. 2004 Oct ;99(4):1193-8, table of contents.

PubMed
Effect of pulsatile flow on microvascular resistance in adult rabbit lungs.
Effect of pulsatile flow on microvascular resistance in adult rabbit lungs.
J Appl Physiol. 1992 Jan ;72(1):73-81.

PubMed
Bedside estimation of absolute renal blood flow and glomerular filtration rate i...
Bedside estimation of absolute renal blood flow and glomerular filtration rate in the intensive care unit. A validation of two independent methods.
Intensive Care Med. 2004 Sep ;30(9):1776-82. Epub 2004 Jul 28 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Use of recombinant factor VIIa (rFVIIa) to control intraoperative bleeding in pediatric brain tumor patients.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information